NCT06662084
The ECMOCYP (cytochromes P450 Activity) Study
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Evaluate the impact of temporary mechanical circulatory support on the activity of CYPs as measured with metabolic ratios MRs (CYP activity at D3 post tMCS implantation and 14 days after tMCS explantation vs the activity of CYPs in the control grou
Timeframe: During the ECMO
Secondary (7)
Evaluate the correlation between the activity of CYPs and IL-6 levels
Evaluate the correlation between the activity of CYPs (MRs) and CRP levels
Evaluate the correlation between the activity of CYPs (MRs) and TNF-α levels
Evaluate the correlation between the activity of CYPs (MRs) and IL-1β levels
Evaluate the correlation between the activity of CYPs (MRs) and IFN-γ levels
Show 2 moreShow less
Compare CYP activity vs expected CYP activity based on patients' CYP genotyping
Compare CYP activity based on phenotyping between VA-EMCO and micro-axial pump device (Impella® CP)
Arms and interventions
Temporary mechanical circulatory support group
Male and female patients presenting a refractory cardiogenic shock, requiring temporary mechanical circulatory support (tMCS), with either the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or a micro-axial pump device (Impella® CP).
Control group
Male and female patients in cardiogenic shock according to the SCAI (Society for Cardiovascular Angiography and Interventions) ESC (European Society of Cardiology) definition and not requiring or not eligible to temporary mechanical circulatory support (tMCS). (e.g. ECMO, Impella®, intra-aortic balloon pump)
Diagnostic tests: phenotype
Sites
1 site in 1 country
- University Hospital Of GenevaGeneva, Switzerland